Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Atibuclimab by Implicit Bioscience for Cardiomyopathy: Likelihood of Approval
Atibuclimab is under clinical development by Implicit Bioscience and currently in Phase II for Cardiomyopathy. According to GlobalData, Phase II...